Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Status unconfirmed · Phase 1

Conditions studied: Breast Cancer

In brief

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Peripheral stem cell transplantation combined with biological therapy may be an effective treatment for breast cancer. PURPOSE: Phase I trial to study the effectiveness of interleukin-2 with filgrastim to stimulate cell production in treating patients with stage IIIB, stage IV, metastatic, or recurrent breast cancer who will undergo peripheral stem cell transplantation.

Key facts

Study ID

NCT00002616

Run by

University of Illinois at Chicago

People needed

36

Starts

1995-02-01

Last updated by the study team

2013-09-20

Who can join

Age: any, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Illinois at Chicago Health Sciences Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.